Paper39009604
Efficient and reproducible generation of human iPSC-derived cardiomyocytes and cardiac organoids in stirred suspension systems.
Prondzynski M and 22 others. Nat Commun, 2024. Cited by 75 papers, by iCite.
Cite this record
ConductScience Library. Efficient and reproducible generation of human iPSC-derived cardiomyocytes and cardiac organoids in stirred suspension systems. Papers, record 39009604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39009604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficient and reproducible generation of human iPSC-derived cardiomyocytes and cardiac organoids in stirred suspension systems.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Induced Pluripotent Stem Cells | Major topic |
| Myocytes, Cardiac | Major topic |
| Organoids | Major topic |
| Cell Differentiation | Major topic |
| Bioreactors | Major topic |
| Cell Culture Techniques | Major topic |
| Humans | |
| Reproducibility of Results | |
| Cells, Cultured | |
| Cryopreservation |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UH3 TR003279 | NCATS NIH HHS | United States | UH3TR003279 | PubMed and NIH | NIH RePORTER |
| UH3HL141798 | U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (NCATS) | UH3HL141798 | PubMed and NIH | NIH RePORTER | |
| R01 HL163937 | NHLBI NIH HHS | United States | R01HL163937 | PubMed and NIH | NIH RePORTER |
| UH3 HL141798 | NHLBI NIH HHS | United States | UH3HL141798 | PubMed and NIH | NIH RePORTER |
| T32 HL007572 | NHLBI NIH HHS | United States | T32HL007572 | PubMed and NIH | NIH RePORTER |
| UH3TR003279 | U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (NCATS) | UH3TR003279 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 38464269 | Efficient and reproducible generation of human iPSC-derived cardiomyocytes using a stirred bioreactor. | https://conductscience.org/library/papers/38464269 |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32078450 | Polyploidy in Cardiomyocytes: Roadblock to Heart Regeneration? | Circ Res | 2020 | https://conductscience.org/library/papers/32078450 | PubMed |
| 2 | 23168164 | Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. | Cell Stem Cell | 2013 | https://conductscience.org/library/papers/23168164 | PubMed |
| 3 | 28624223 | Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes. | Mol Ther Nucleic Acids | 2017 | https://conductscience.org/library/papers/28624223 | PubMed |
| 4 | 29741611 | CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy. | Eur Heart J | 2018 | https://conductscience.org/library/papers/29741611 | PubMed |
| 5 | 28492526 | Differentiation of cardiomyocytes and generation of human engineered heart tissue. | Nat Protoc | 2017 | https://conductscience.org/library/papers/28492526 | PubMed |
| 6 | 33338435 | Effects of Cryopreservation on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Assessing Drug Safety Response Profiles. | Stem Cell Reports | 2021 | https://conductscience.org/library/papers/33338435 | PubMed |
| 7 | 31311300 | Insights Into the Pathogenesis of Catecholaminergic Polymorphic Ventricular Tachycardia From Engineered Human Heart Tissue. | Circulation | 2019 | https://conductscience.org/library/papers/31311300 | PubMed |
| 8 | 26270394 | Cardiac differentiation of human pluripotent stem cells in scalable suspension culture. | Nat Protoc | 2015 | https://conductscience.org/library/papers/26270394 | PubMed |
| 9 | 18236465 | Drug-screening platform based on the contractility of tissue-engineered muscle. | Muscle Nerve | 2008 | https://conductscience.org/library/papers/18236465 | PubMed |
| 10 | 34446706 | Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease. | Nat Commun | 2021 | https://conductscience.org/library/papers/34446706 | PubMed |
| 11 | 35931080 | Physiological calcium combined with electrical pacing accelerates maturation of human engineered heart tissue. | Stem Cell Reports | 2022 | https://conductscience.org/library/papers/35931080 | PubMed |
| 12 | 37012447 | Epicardioid single-cell genomics uncovers principles of human epicardium biology in heart development and disease. | Nat Biotechnol | 2023 | https://conductscience.org/library/papers/37012447 | PubMed |
| 13 | 36078153 | ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes. | Cells | 2022 | https://conductscience.org/library/papers/36078153 | PubMed |
| 14 | 34019794 | Cardioids reveal self-organizing principles of human cardiogenesis. | Cell | 2021 | https://conductscience.org/library/papers/34019794 | PubMed |
| 15 | 29109393 | Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. | Nat Commun | 2017 | https://conductscience.org/library/papers/29109393 | PubMed |
| 16 | 26971820 | CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs. | Cell Stem Cell | 2016 | https://conductscience.org/library/papers/26971820 | PubMed |
| 17 | 22905142 | Nuclear morphometric analysis (NMA): screening of senescence, apoptosis and nuclear irregularities. | PLoS One | 2012 | https://conductscience.org/library/papers/22905142 | PubMed |
| 18 | 27929521 | Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies. | Nat Protoc | 2017 | https://conductscience.org/library/papers/27929521 | PubMed |
| 19 | 25240927 | Generation of the epicardial lineage from human pluripotent stem cells. | Nat Biotechnol | 2014 | https://conductscience.org/library/papers/25240927 | PubMed |
| 20 | 29178315 | 3D aggregate culture improves metabolic maturation of human pluripotent stem cell derived cardiomyocytes. | Biotechnol Bioeng | 2018 | https://conductscience.org/library/papers/29178315 | PubMed |
Cited by61
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948879 | RBFOX2 Autoregulation Promotes Cardiomyocyte Transcriptome Maturation and Differentiation. | Circ Res | 2026 | https://conductscience.org/library/papers/42948879 | PubMed |
| 42884039 | Ambient Temperature Preservation Supports Recovery of Beating Capacity in Human Cardiac Organoids After Exposure to Simulated Space Stressors. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42884039 | PubMed |
| 42842671 | Self-buoyant cell-spheroid culture programming multi-spheroid assembly. | Sci Adv | 2026 | https://conductscience.org/library/papers/42842671 | PubMed |
| 42756683 | Reconstructing AF-associated atrial fibrosis: Patient-specific iPSC models, fit-for-purpose atrial microphysiological systems, and nanomedicine. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42756683 | PubMed |
| 42742929 | Humanized hiPSC Platforms for I/R Injury: Advancing Toward Precision Cardioprotection. | Cardiovasc Ther | 2026 | https://conductscience.org/library/papers/42742929 | PubMed |
| 42724214 | Emerging genes implicated in human congenital heart disease: a 2023-2025 scoping review. | Transl Pediatr | 2026 | https://conductscience.org/library/papers/42724214 | PubMed |
| 42645910 | Therapeutic Target Mapping to Advance Drug Repurposing for Cardiovascular Disease: A Perspective from an Explanted Heart Biobank. | J Pers Med | 2026 | https://conductscience.org/library/papers/42645910 | PubMed |
| 42603976 | Integrating delivery systems and microenvironmental cues to accelerate clinical translation of cardiac reprogramming. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42603976 | PubMed |
| 42587726 | Genetic and Epigenetic Regulation of Cardiac Development: An Integrative View from Embryo to Human Pluripotent Stem Cell Models. | Cells | 2026 | https://conductscience.org/library/papers/42587726 | PubMed |
| 42556342 | Clinical landscape of human pluripotent stem cell-derived cardiomyocyte therapy. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42556342 | PubMed |
| 42489567 | Analysis of gene expression changes upon topobexin treatment and TOP2B-knockout in hiPSC-derived cardiomyocytes. | Biol Open | 2026 | https://conductscience.org/library/papers/42489567 | PubMed |
| 42465381 | Xeno-Free Peptide-Functionalized Hydrogels Support hiPSC Encapsulation and In Situ Differentiation into Structurally Mature Cardiomyocytes. | bioRxiv | 2026 | https://conductscience.org/library/papers/42465381 | PubMed |
| 42428810 | Structural and functional benchmarking of monolayer- and bioreactor-generated hiPSC-derived cardiomyocytes. | APL Bioeng | 2026 | https://conductscience.org/library/papers/42428810 | PubMed |
| 42421236 | Human iPSC-derived 3D cardiac models for cardiomyopathies: organoids, spheroids, and engineered heart tissues as translational platforms. | Stem Cells | 2026 | https://conductscience.org/library/papers/42421236 | PubMed |
| 42393174 | Cryopreservation alters contractile function of human induced pluripotent stem cell-derived cardiomyocytes. | Sci Rep | 2026 | https://conductscience.org/library/papers/42393174 | PubMed |
| 42356581 | Human Hematopoietic Stem Cells Enhance Maturational Differentiation of hiPSC-Derived Cardiomyocytes on Xeno-Free MatriClone-Plastic via EGFR/MAPK/ERK Signaling Pathway. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42356581 | PubMed |
| 42274611 | Engineering Human Myocardium: Integrating the Maturation of hiPSC-Derived Cardiac Myocytes Across Genetic, Structural, Physiological and Multicellular Systems. | Cells | 2026 | https://conductscience.org/library/papers/42274611 | PubMed |
| 42194102 | Current Progress and Future Outlook for Synthetic Gene Circuits in Cardiovascular Therapy. | Biomolecules | 2026 | https://conductscience.org/library/papers/42194102 | PubMed |
| 42093157 | An RYR2-interacting fragment of MYBPC3 mitigates arrhythmia in human iPSC-CM and mouse models of CPVT. | Mol Ther | 2026 | https://conductscience.org/library/papers/42093157 | PubMed |
| 42010330 | PCBP1 regulates alternative splicing of AARS2 in congenital cardiomyopathy. | Nat Cardiovasc Res | 2026 | https://conductscience.org/library/papers/42010330 | PubMed |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE263372 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39009604
GET https://conductscience.org/api/papers/v1/39009604/authors?page=2